<DOC>
	<DOCNO>NCT02948842</DOCNO>
	<brief_summary>The purpose study assess efficacy clostridium histolyticum collagenase ( XIAFLEX® ) treat urethral stricture .</brief_summary>
	<brief_title>Clostridium Histolyticum Collagenase Injection Urethral Disease</brief_title>
	<detailed_description>This open-label , pilot study explore efficacy clostridium histolyticum collagenase ( XIAFLEX® ) treat urethral stricture . Subjects follow 2 year initial drug treatment .</detailed_description>
	<mesh_term>Urethral Stricture</mesh_term>
	<mesh_term>Urethral Diseases</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Males Age ≥ 18 year Failed prior proven conservative measure , include DVIU balloon dilation stricture include study Able willing undergo regular intervention well evaluation describe include study With single stricture &lt; 2cm size identify retrograde urethrogram void cystourethrogram include study . Must agree participate clinical study involve another investigational drug device throughout duration study Must competent understand information give IRB approve ICF must sign form prior initiation study procedure Has yet undergone proven noninvasive measure , include DVIU balloon dilation . Multiple stricture single stricture large 2cm size , measure retrograde urethrogram void cystourethrogram . Age &lt; 18 Females Prior urethroplasty Urethral fistula Allergy sensitivity CHC Bleeding disorder anticoagulant use aspirin 150mg/day Untreated urinary tract infection Inability perform intermittent selfcatheterization Participation another clinical study treatment investigational drug device Serious active medical psychiatric condition , opinion Investigator , may interfere treatment , assessment , compliance protocol</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>